Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,100 | 106 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $189.58 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $180.67 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $174.66 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $164.54 | 6 | $0 (2024) |
| Eisai Inc. | $145.97 | 7 | $0 (2024) |
| Incyte Corporation | $134.60 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $133.63 | 8 | $0 (2024) |
| Amgen Inc. | $98.86 | 6 | $0 (2023) |
| Genentech USA, Inc. | $77.47 | 5 | $0 (2024) |
| Integra LifeSciences Corporation | $61.31 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $809.34 | 41 | Novartis Pharmaceuticals Corporation ($115.28) |
| 2023 | $802.70 | 40 | Bayer Healthcare Pharmaceuticals Inc. ($107.00) |
| 2022 | $449.78 | 23 | EISAI INC. ($104.54) |
| 2019 | $38.06 | 2 | CooperSurgical, Inc. ($25.86) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.37 | General |
| 12/10/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| Category: Hematology/Oncology | ||||||
| 12/09/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $17.83 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.22 | General |
| 11/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $27.21 | General |
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: BIOLOGIC | ||||||
| 10/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Biological | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Genentech USA, Inc. | Alecensa (Biological), Tecentriq, Tecentriq Hybreza | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: BioOncology | ||||||
| 09/17/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Genentech USA, Inc. | Phesgo (Biological), Polivy | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: BioOncology | ||||||
| 09/11/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.35 | General |
| Category: Hematology/Oncology | ||||||
| 08/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Oncology | ||||||
| 07/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $20.01 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 11 | $765.60 | $556.89 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 11 | $765.60 | $556.89 | 72.7% |
About Dr. Robert Perry, M.D
Dr. Robert Perry, M.D is a Obstetrics & Gynecology healthcare provider based in Rushville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992787246.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Perry, M.D has received a total of $2,100 in payments from pharmaceutical and medical device companies, with $809.34 received in 2024. These payments were reported across 106 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($2,100).
As a Medicare-enrolled provider, Perry has provided services to 11 Medicare beneficiaries, totaling 11 services with total Medicare billing of $556.89. Data is available for 1 year (2022–2022), covering 1 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Gynecology
- Location Rushville, IN
- Active Since 11/14/2005
- Last Updated 02/18/2025
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1992787246
Products in Payments
- KEYTRUDA (Biological) $180.67
- Lenvima (Drug) $145.97
- JAKAFI (Drug) $101.41
- LYNPARZA (Drug) $74.45
- KISQALI (Drug) $71.75
- Stivarga (Drug) $70.26
- Nubeqa (Drug) $64.07
- Integra (Device) $61.31
- JEVTANA (Drug) $51.05
- ICLUSIG (Drug) $50.27
- LUMAKRAS (Drug) $49.59
- Alecensa (Biological) $44.70
- SCEMBLIX (Drug) $43.53
- Enhertu (Drug) $43.51
- Mirena (Drug) $40.33
- Veozah (Drug) $39.68
- ADCETRIS (Biological) $36.96
- Kyprolis (Drug) $35.83
- DARZALEX (Biological) $35.78
- ZEPZELCA (Drug) $34.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.